Form 4: Ultragenyx Pharmaceutical Inc. Executive Sells Shares to Cover Tax Obligations

Theodore Alan Huizenga, SVP and Chief Accounting Officer of Ultragenyx Pharmaceutical Inc., disposed of 14 shares of common stock to cover tax withholdings related to vesting RSUs.

Summary

• On April 16, 2024, Theodore Alan Huizenga, SVP, Chief Accounting Officer of Ultragenyx Pharmaceutical Inc., disposed of 14 shares of common stock.
• The transaction was executed to cover required tax withholdings due to the vesting of Restricted Stock Units (RSUs).
• The shares were sold at a price of $42.31 per share.
• Following the transaction, Huizenga beneficially owns 41,366 shares of Ultragenyx Pharmaceutical Inc.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine transaction to cover tax obligations and doesn't necessarily indicate a change in the executive's confidence in the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track executive sentiment and potential alignment with company performance. This transaction is a routine sale to cover tax obligations, which is a common occurrence when RSUs vest.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, as it is a small number of shares sold to cover tax obligations.

Key Dates